This is a StreetInsider.com Premium Only Page

Spectrum Pharma (SPPI) – Globe Newswire

Jul 31, 2023 07:27 PM Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction

Jul 27, 2023 04:01 PM Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals

Apr 25, 2023 06:00 AM Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction

Jan 10, 2023 07:15 PM ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action– SPPI

Jan 2, 2023 07:30 PM ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm– S

Dec 2, 2022 08:50 PM Bragar Eagel & Squire, P.C. Is Investigating Spectrum, F45 Training, PROG, and Fox and Encourages Investors to Contact the Firm

Nov 27, 2022 08:40 PM Bragar Eagel & Squire, P.C. Is Investigating GrafTech, Cantaloupe, Spectrum, and F45 Training and Encourages Investors to Contact the Firm

Nov 16, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating GrafTech, Cantaloupe, Spectrum, and F45 Training and Encourages Investors to Contact the Firm

Nov 6, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Cantaloupe, EyePoint, Spectrum, and F45 Training and Encourages Investors to Contact the Firm

Oct 21, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Spectrum, F45 Training, PROG, and UiPath and Encourages Investors to Contact the Firm

Oct 16, 2022 11:09 PM Bragar Eagel & Squire, P.C. Is Investigating EyePoint, Spectrum, F45, and PROG and Encourages Investors to Contact the Firm

Oct 11, 2022 09:58 PM Bragar Eagel & Squire, P.C. Is Investigating EyePoint, Spectrum, and F45 and Encourages Investors to Contact the Firm

Oct 2, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Cantaloupe, Compass, and Spectrum and Encourages Investors to Contact the Firm

Oct 27, 2021 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spectrum and loanDepot and Encourages Investors to Contact the Firm

Oct 19, 2021 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Katapult, HyreCar, Spectrum, and loanDepot and Encourages Investors to Contact the Firm

Oct 13, 2021 10:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Katapult, HyreCar, Spectrum, and loanDepot and Encourages Investors to Contact the Firm

Oct 7, 2021 10:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ATI, View, and Spectrum and Encourages Investors to Contact the Firm

Oct 2, 2021 08:00 AM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ATI, View, and Spectrum and Encourages Investors to Contact the Firm

Sep 27, 2021 09:09 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Iterum, View, and Spectrum and Encourages Investors to Contact the Firm

Sep 22, 2021 09:07 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Iterum, View, and Spectrum and Encourages Investors to Contact the Firm

Sep 15, 2021 08:58 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coinbase, Annovis Bio, and Spectrum and Encourages Investors to Contact the Firm

Sep 8, 2021 09:04 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coinbase, Annovis Bio, and Spectrum and Encourages Investors to Contact the Firm

Dec 17, 2020 08:00 AM BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors

Mar 2, 2020 08:00 AM The Rosen Law Firm P.A. and Bronstein Gewirtz & Grossman, LLC Announce Proposed Class Action Settlement on Behalf of Purchasers of Securities of Spectrum Pharmaceuticals, Inc. -- SPPI